tiprankstipranks
Urologix (ULGX)
OTHER OTC:ULGX
US Market

Urologix (ULGX) Stock Price & Analysis

6 Followers

ULGX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume250.00
Average Volume (3M)N/A
Market Cap
$2.18K
Enterprise Value$4.84M
Total Cash (Recent Filing)$492.00K
Total Debt (Recent Filing)$5.33M
Price to Earnings (P/E)N/A
Beta-79.33
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,817,726
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation17.93
R-Squared0.07
Alpha4.29
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.40
Enterprise Value/Gross Profit0.79
Enterprise Value/Ebitda-9.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

10.76%0.00%0.18%89.05%
10.76%
Insiders
0.18% Other Institutional Investors
89.05% Public Companies and
Individual Investors

ULGX FAQ

What was Urologix’s price range in the past 12 months?
Currently, no data Available
What is Urologix’s market cap?
Currently, no data Available
When is Urologix’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Urologix’s earnings last quarter?
Currently, no data Available
Is Urologix overvalued?
According to Wall Street analysts Urologix’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Urologix pay dividends?
    Urologix does not currently pay dividends.
    What is Urologix’s EPS estimate?
    Urologix’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Urologix have?
    Urologix has 21,818,000 shares outstanding.
      What happened to Urologix’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Urologix?
      Currently, no hedge funds are holding shares in ULGX
      ---

      Urologix Stock Smart Score

      N/A
      Not Ranked
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Urologix

      Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Medigus
      Viveve Medical
      Jaguar Animal Health
      ADMA Biologics
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis